Skip to main content

Eosinophilic keratitis in cats - Health News

Stiles J, Coster M.  Use of an ophthalmic formulation of megestrol acetate for the treatment of eosinophilic keratitis in cats.  Vet Ophthalmol. 2016;19 (Suppl 1):86-90.

cat faceEosinophilic keratitis (EK), also called proliferative keratitis, is a relatively common feline eye disorder of unknown etiopathogenesis.  Feline herpesvirus-1 (FHV-1) was associated with this condition in one study that identified this virus in the corneas of cats with EK using a polymerase chain reaction (PCR) assay.   However, many cats with EK do not have a history or clinical signs that would be associated with FHV-1 infection.  It is also possible that the inflammation associated with EK could lead to recrudescence of latent FHV-1 infection.  Given that a single eye is usually initially affected by EK, it is easy to assume that EK might be associated with FHV-1, but the condition can progress to both eyes. Ultraviolet light may be a trigger for the development of EK.

In EK there is generally conjunctival hyperemia, corneal neovascularization, and a visible cellular corneal stromal cellular infiltrate that eventually develops into a whitish, proliferative plaque that often starts at the dorsolateral limbus or near the medial canthus.  Tearing, whitish mucoid ocular discharge, and blepharospasm usually accompany EK, and over time the cat is likely to become progressively more uncomfortable.  Diagnosis of EK is accomplished through cytology of corneal or conjunctival samples taken with a cytobrush or small blunt collection device such as a spatula.  In EK, cytological samples will contain eosinophils, mast cells, neutrophils, lymphocytes, plasma cells, and occasionally, histiocytes.

Anti-inflammatory drugs, either systemic or topical, are the mainstay of treatment for EK.  Topical glucocorticoids, such as prednisolone acetate 1% or dexamethasone 0.1% are frequently used, but may result in recrudescence of FHV-1 if present.  Successful use of topical 1.5% cyclosporine has also been reported, as well as combination therapy with a topical nonsteroidal anti-inflammatory and 0.2% cyclosporine ointment.  Concurrent treatment of the eye with a topical antiviral medication, if available, may be prudent when topical glucocorticoids or cyclosporine are used, given the potential for recrudescence of FHV-1 in feline patients.  Eosinophilic keratitis can become chronic, and require extended ongoing treatment, sometimes lifelong.

Some cats with EK have been treated very succesfully with oral megestrol acetate, a potent progestogen with glucocorticoid-like activity.  However, the side effects of using this drug systemically may outweigh the benefits as they are serious and may include diabetes mellitus, adrenal suppression, weight gain, mammary hyperplasia or neoplasia, and behavior changes. 

In this prospective study of 17 client-owned cats with EK in one or both eyes, these investigators evaluated treatment with a topical ophthalmic formulation of megestrol acetate, hypothesizing that the topical megestrol acetate would resolve the EK lesions with no systemic adverse effects.  Cats recruited into the study had EK confirmed by cytology, did not have signs of active FHV-1-associated disease, and had not experienced recent prior treatment with topical or systemic antiviral or anti-inflammatory drugs including megestrol acetate. Sixteen of the cats were mixed breed domestic shorthair or longhair, and one cat was a Persian; they ranged in age from 3 to 17 years, with a mean age of 7.3 years.

The topical medication, prepared by a compounding pharmacist, consisted of 0.5% megestrol acetate in an aqueous base. This was first tested on seven healthy cats without ocular disease to verify that the medication itself did not cause ocular irritation.  In the 17 study patients with EK, the topical megestrol acetate 0.5% preparation was given at one drop in the affected eye(s) every 8-12 hours, depending on the severity of the lesions.  The cats' owners were advised to monitor their pets at home for signs of ocular irritation or potential systemic side effects such as polyuria or polydipsia, weight gain, or depression.  The patients also had clinical ophthalmologic examinations every 2-4 weeks after starting treatment, and serum glucose measurements were performed at the first or second clinical re-examination appointment.  No adrenal function testing was performed.

The majority of the patients (15/17; 88%) had a positive response to treatment; their eosinophilic plaques either diminished in size or resolved, the corneal neovascularization regressed, and any previously noted fluorescein-positive areas on their corneas resolved.  Six of the 15 cats considered successfully treated (35%) had complete resolution of the lesions by the first clinical re-examination, while another eight demonstrated improvement but not complete resolution. The eight cats who had only partial resolution by the first clinical re-examination progressed to complete resolution within six weeks.  The other cat (1/15) improved gradually and achieved complete resolution at 3 months.  The two cats (2/17; 12%) who did not improve, one after 3 weeks, and the other after 3 months, were dropped from the study and had their therapy changed.

Ten of the 17 cats had serum glucose levels evaluated at various points during the study, and all were within the reference range except for one cat who had pre-existing diabetes mellitus.  This diabetic cat did not experiencing worsening of its diabetes regulation while receiving the topical megestrol acetate.  Tapering of the frequency of daily treatment was based on the severity of initial disease and clinical response in each patient. None of the cats developed clinical signs consistent with chronic-active FHV-1 during the course of treatment, even when this was prolonged.  Six of the 17 cats had positive fluorescein uptake at their initial examination, and all such lesions went on to heal while the patients were receiving the topical megestrol acetate.   The use of topical ophthalmic 0.5% megestrol acetate in aqueous solution is a viable option for treating feline EK, and is unlikely to cause significant systemic side effects; nonetheless, monitoring of patients receiving this therapy for potential systemic adverse effects is prudent. [PJS]

See also:
Dean E, Meunier V.  Feline eosinophilic keratoconjunctivitis: a retrospective study of 45 cases. J Feline Med Surg 2013;15:661-6.


from Cat Health News from the Winn Feline Foundation - Health News


  1. Very informative and impressive post you have written, this is quite interesting and i have went through it completely, an upgraded information is shared, keep sharing such valuable information. Private Health Assessment Sydney Australia

  2. Hi There,
    Thank you for sharing the knowledgeable blog with us I hope that you will post many more blog with us:-
    It comes in clear crystal chunks or shiny blue-white rocks. Also called “ice” or “glass,” it's a popular party drug. Usually, users smoke crystal meth.
    Click here for more information:- more info

  3. Hello everyone, I want to say a special thanks to Dr OGU. for helping me get cured from herpes virus 2019 , I contacted him base on the testimonies I saw about him on the internet I was diagnosed of HERPES Virus i have tried all I can to get cured but all to know avail, until i saw a post in a health forum about a herbal man who prepare herbal medication to cure all kind of diseases including HERPES virus, at first i doubted if it was real but decided to give it a try I was cured by his herbal medicine and natural herbs, kindly contact him today through his email: or text/call: +1 (719) 629 0982

    He’s waiting to help you.


    If you have any sickness like : H I V/AIDS , CANCER , HERPES 1 or 2 , GENITAL WARTS (HPV), and Hepatitis B. Trichomoniasis Gonorrhea, Epilepsy, and Syphilis.

  4. When the software becomes more complex, it can be more difficult, time-consuming, and boring to identify bugs. So, to make fewer mistakes and accelerate the entire development process, we use automated testing, where both developers and QA engineers write tests.


  5. I was diagnosed as HEPATITIS B carrier in 2013 with fibrosis of the
    liver already present. I started on antiviral medications which
    reduced the viral load initially. After a couple of years the virus
    became resistant. I started on HEPATITIS B Herbal treatment from
    ULTIMATE LIFE CLINIC ( in March, 2020. Their
    treatment totally reversed the virus. I did another blood test after
    the 6 months long treatment and tested negative to the virus. Amazing
    treatment! This treatment is a breakthrough for all HBV carriers.


Post a Comment

Popular posts from this blog

Annual health policy forum Sept. 23 to focus on medical marijuana, a topic sure to come up again in the next legislative session - Health News

By Melissa Patrick Kentucky Health News The Foundation for a Healthy Kentucky's annual policy forum this fall will be dedicated to the topic of medical marijuana in hopes of separating what is fact and what is myth, and to better understand how legalizing it would affect public health and society as a whole in Kentucky. "It's our judgment that there is a lot of misinformation out there, a lot of confusion about what the facts really are," said Ben Chandler, president and CEO of the foundation. "And we are going to try to shine a light on those facts as best we can." The Howard L. Bost Health Policy Forum is sponsored by the foundation in memory of the physician who helped create Medicare and Medicaid, developed the Appalachian Regional Hospital system, improved mental health services in Kentucky and created the vision for the foundation. It will be held at the Marriott Griffin Gate Resort in Lexington on Monday, Sept. 23. The full agenda and regist

Playing board games may help protect thinking skills in old age - health news

People who play games - such as cards and board games - are more likely to stay mentally sharp in later life, a study suggests. Those who regularly played non-digital games scored better on memory and thinking tests in their 70s, the research found. The study also found that a behaviour change in later life could still make a difference. People who increased game playing during their 70s were more likely to maintain certain thinking skills as they grew older. Psychologists at the University of Edinburgh tested more than 1000 people aged 70 for memory, problem solving, thinking speed and general thinking ability. The participants then repeated the same thinking tests every three years until aged 79. The group were also asked how often they played games like cards, chess, bingo or crosswords - at ages 70 and 76. Researchers used statistical models to analyse the relationship between a person's level of game playing and their thinking skills. The team took into accou